A detailed history of Parallel Advisors, LLC transactions in Morpho Sys Ag stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,492 shares of MOR stock, worth $27,751. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,492
Previous 1,492 -0.0%
Holding current value
$27,751
Previous $14,000 92.86%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$4.55 - $9.9 $5,241 - $11,404
1,152 Added 338.82%
1,492 $14,000
Q3 2023

May 20, 2024

BUY
$6.72 - $8.6 $887 - $1,135
132 Added 63.46%
340 $2,000
Q3 2023

Nov 13, 2023

BUY
$6.72 - $8.6 $887 - $1,135
132 Added 63.46%
340 $2,000
Q2 2023

May 20, 2024

SELL
$3.95 - $7.74 $5,071 - $9,938
-1,284 Reduced 86.06%
208 $1,000
Q2 2023

Aug 04, 2023

BUY
$3.95 - $7.74 $821 - $1,609
208 New
208 $1,000
Q2 2022

Aug 01, 2022

BUY
$4.51 - $7.39 $6,873 - $11,262
1,524 New
1,524 $7,000

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Market Cap $2.54B
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.